3 completed, 2 not yet recruiting, 2 unknown. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Pathological Myopia: new trials by email Literature Review of Pathological Myopia trials Research Report on Pathological Myopia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retinal Clinical Assessment With AI-derived Quantitative Information AI-derived retinal quantitative information-assisted reporting - no Obvious Abnormalities, Diabetic Retinopathy (DR) | Not yet recruiting | Beijing Tongren Hospital | 29 | 2026-04-15 | 2026-04-29 | |
| An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings With fundus diseases, Without fundus diseases - Retinal Diseases, Choroidal Disease | Not yet recruiting | Zhongshan Ophthalmic Center, Sun Yat-sen University | 9999 | 2025-05-01 | 2025-04-09 | |
| Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases Intravitreal injection of conbercept - Age-Related Macular Degeneration, Polypoidal Choroidal Vasculopathy | Unknown | Xun Xu | 5000 | 2017-02-28 | 2017-04-25 | |
| Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia Ranibizumab, Verteporfin PDT, Sham Ranibizumab - Pathological Myopia | Phase 3 | Completed | Novartis Pharmaceuticals | 277 | 2010-10-01 | 2014-02-10 |
| Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy ranibizumab injection (0.5 mg) - Coats' Disease, Idiopathic Retinal Telangiectasia | Phase 1 / Phase 2 | Completed | Manhattan Eye, Ear & Throat Hospital | 18 | 2007-05-01 | 2012-10-25 |
| Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) Bevacizumab - Choroidal Neovascularization, Degenerative Myopia | Phase 1 | Completed | Johns Hopkins University | 10 | 2005-06-01 | 2009-02-03 |
| Genomewide Screening of Pathological Myopia Pathological Myopia | Unknown | National Taiwan University Hospital | 600 | 2002-08-01 | 2010-06-09 |
Myopia, Degenerative (7) · Choroidal Neovascularization (3) · Diabetic Retinopathy (2) · Macular Degeneration (2) · Polypoidal Choroidal Vasculopathy (2) · Choroid Diseases (1) · Epiretinal Membrane (1) · Pseudoxanthoma Elasticum (1) · Retinal Diseases (1) · Retinal Perforations (1) · Retinal Telangiectasis (1) · Retinal Vein Occlusion (1) · Vitelliform Macular Dystrophy (1) · von Hippel-Lindau Disease (1)
Eye Diseases (7) · Myopia (7) · Refractive Errors (7) · Metaplasia (5) · Neovascularization, Pathologic (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Uveal Diseases (5) · Choroid Diseases (4) · Cardiovascular Diseases (3) · Retinal Degeneration (3) · Retinal Diseases (3) · Vascular Diseases (3) · Choroidal Neovascularization (2) · Diabetes Complications (2)
Ranibizumab (2) · Bevacizumab (1)
Beijing Tongren Hospital (1) · Johns Hopkins University (1) · Manhattan Eye, Ear & Throat Hospital (1) · National Taiwan University Hospital (1) · Novartis Pharmaceuticals (1) · Xun Xu (1) · Zhongshan Ophthalmic Center, Sun Yat-sen University (1)
China (2) · Austria (1) · Canada (1) · France (1) · Germany (1) · Hong Kong (1) · Hungary (1) · India (1) · Italy (1) · Japan (1) · Latvia (1) · Lithuania (1) · Poland (1) · Portugal (1) · Singapore (1)
Lawrence A. Yannuzzi, MD (1) · Quan D Nguyen, MD, MSc (1) · Yung-Feng Shih, MD (1)
PMID 18054887, PMID 24326106, PMID 25109929, PMID 30041608, PMID 41023746